Jefferies Downgrades Fusion Pharmaceuticals (FUSN) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. JBLU
3. CDNS
4. META
5. ANT
6. PECO
7. SSD
8. AGYS
9. HWKN
10. INTC

Go back to Jefferies Downgrades Fusion Pharmaceuticals (FUSN) to Hold

Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer

March 19, 2024 3:00 AM EDT

Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities

Fusion shareholders to receive $21.00 per share in cash at closing plus a non-transferrable contingent value right (CVR) of $3.00 per share, representing a total transaction value of approximately $2.4 billion including the CVR

HAMILTON, ON and BOSTON, March 19,... More